6 months of tirzepatide months, 26 shots, and 128 lbs down — has truly changed my life : r/Zepbound Tirzepatide Results at 6 Months:

(3) Notably, only 53.8% of those prescribed a GLP-1 agonist in 2022 had a history of type 2 diabetes, highlighting a shifting clinical paradigm in which these agents are now widely used for obesity management and related metabolic disorders

PMID: 34463662

Also be sure to check out the GLP-1 and GIP, GLP-1 Receptor Agonist Interactive Comparison Chart on our Pharmacist Letter and Pharmacy Technicians Letter website

Counsel patients regarding the potential risk for MTC with the use of Ozempic or Rybelsus tablets and inform them of symptoms of thyroid tumors (e.g

doi: 10.3389/fimmu.2024.1362501 Received 28 December 2023 Accepted 01 April 2024 Published 17 April 2024 Volume 15 - 2024 Edited by Sladjana Sobajic, University of Belgrade, Serbia Reviewed by Md Tajmul, National Institute of Diabetes and Digestive and Kidney Diseases (NIH), United States Jadranka Vranekovi, University of Rijeka, Croatia Updates Copyright 2024 Ramacieri, Locatelli, Semprini, Pelleri, Caracausi, Piovesan, Cicilloni, Vigna, Vitale, Sperti, Corvaglia, Pirazzoli, Strippoli, Catapano, Vione and Antonaros

Comparative Perspective Retatrutide belongs to a newer generation of weight loss drugs that target three separate metabolic pathways